Umbilical cord blood DNA methylation in children who later develop type 1 diabetes

Author:

Laajala EssiORCID,Kalim Ubaid UllahORCID,Grönroos ToniORCID,Rasool OmidORCID,Halla-aho ViiviORCID,Konki MikkoORCID,Kattelus RoosaORCID,Mykkänen JuhaORCID,Nurmio MirjaORCID,Vähä-Mäkilä MariORCID,Kallionpää HennaORCID,Lietzén NiinaORCID,Ghimire Bishwa R.ORCID,Laiho AstaORCID,Hyöty HeikkiORCID,Elo Laura L.ORCID,Ilonen JormaORCID,Knip MikaelORCID,Lund Riikka J.ORCID,Orešič MatejORCID,Veijola RiittaORCID,Lähdesmäki HarriORCID,Toppari JormaORCID,Lahesmaa RiittaORCID

Abstract

Abstract Aims/hypothesis Distinct DNA methylation patterns have recently been observed to precede type 1 diabetes in whole blood collected from young children. Our aim was to determine whether perinatal DNA methylation is associated with later progression to type 1 diabetes. Methods Reduced representation bisulphite sequencing (RRBS) analysis was performed on umbilical cord blood samples collected within the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) Study. Children later diagnosed with type 1 diabetes and/or who tested positive for multiple islet autoantibodies (n = 43) were compared with control individuals (n = 79) who remained autoantibody-negative throughout the DIPP follow-up until 15 years of age. Potential confounding factors related to the pregnancy and the mother were included in the analysis. Results No differences in the umbilical cord blood methylation patterns were observed between the cases and controls at a false discovery rate <0.05. Conclusions/interpretation Based on our results, differences between children who progress to type 1 diabetes and those who remain healthy throughout childhood are not yet present in the perinatal DNA methylome. However, we cannot exclude the possibility that such differences would be found in a larger dataset. Graphical abstract

Funder

European Foundation for the Study of Diabetes

Jane ja Aatos Erkon Säätiö

H2020 European Research Council

Business Finland

Finnish Diabetes Foundation

Academy of Finland

JDRF

Finnish Cancer Foundation

Suomen Kulttuurirahasto

Pediatric Research Foundation

Novo Nordisk Fonden

Sigrid Jusélius Foundation

ELIXIR Finland

Kyllikki and Uolevi Lehikoinen Foundation

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3